Obeticholic acid, a farnesoid X receptor (FXR) agonist, when loaded into exosomes, represents a promising approach associated with the inactivation of HSCs, ECM remodeling, and the FXR-Cyp7a1 cascade on CCl4-induced liver fibrosis in mice [92]. This evidence concerns the gene NR1H4 and Hepatic fibrosis.